RPG Investment Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100
Closed -$23K 223
2021
Q3
$23K Hold
100
﹤0.01% 165
2021
Q2
$23K Sell
100
-100
-50% -$20.1K ﹤0.01% 167
2021
Q1
$37K Sell
200
-12
-6% -$2.35K 0.01% 139
2020
Q4
$36K Sell
212
-8
-4% -$1.19K 0.01% 131
2020
Q3
$33K Hold
220
0.01% 115
2020
Q2
$36K Hold
220
0.01% 109
2020
Q1
$31K Hold
220
0.01% 116
2019
Q4
$29K Hold
220
0.01% 117
2019
Q3
$25K Sell
220
-164
-43% -$18.3K 0.01% 130
2019
Q2
$43K Hold
384
0.01% 110
2019
Q1
$50K Sell
384
-5
-1% -$608 0.01% 112
2018
Q4
$45K Sell
389
-19
-5% -$2.12K 0.01% 113
2018
Q3
$44K Buy
408
+44
+12% +$4.4K 0.01% 121
2018
Q2
$31K Hold
364
0.01% 146
2018
Q1
$28K Hold
364
0.01% 194
2017
Q4
$31K Hold
364
0.01% 182
2017
Q3
$31K Buy
+364
New +$29.9K 0.01% 173

Other funds holding LLY

RPG Investment Advisory's LLY Position: Q4 2021 in Review

RPG Investment Advisory sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 100 shares — an estimated $23K sold.

RPG Investment Advisory first reported a position in LLY in Q3 2017 and held it in 17 quarters. The position peaked at $50K in Q1 2019. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • RPG Investment Advisory reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • RPG Investment Advisory sold 100 Eli Lilly shares in Q4 2021, an estimated $23K.
  • RPG Investment Advisory first reported a position in Eli Lilly in Q3 2017 and held it in 17 quarters.
  • RPG Investment Advisory's Eli Lilly position peaked at $50K in Q1 2019.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on RPG Investment Advisory's 13F filing for Q4 2021, filed 28 Jan 2022.